Doxazosin Mesylate Tablet
Product Images NDC 59762-1388

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 59762-1388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Structural Formula (Image 01)

Chemical structure of doxazosin mesylate displayed as a 2D molecular diagram, showing its detailed atomic connectivity and arrangement.*

FDA Label Image

Table 3. (Image 02)

Table summarizing effectiveness data from placebo-controlled trials of doxazosin mesylate (CARDURA). It shows symptom score and maximum flow rate changes across three studies, comparing placebo with 4 mg and 8 mg doses. The table includes mean baseline values, mean changes, number of patients, and statistical significance. Adjacent bar graph illustrates maximum flow rate changes for placebo, 4 mg, and 8 mg doses from Study 2.*

FDA Label Image

Figure 1 – Study 1 (Image 03)

Two line graphs comparing treatment effects of doxazosin mesylate (Cardura) versus placebo over 14 weeks. The left graph shows mean change in total symptom score from baseline, indicating greater symptom reduction with Cardura. The right graph shows mean increase in maximum urinary flow rate from baseline, with Cardura demonstrating higher flow rate improvement compared to placebo. Each graph includes sample sizes and significance markers.*

FDA Label Image

Doxazosin Tablets Bottle Labels 1 mg (Image 04)

Label for Greenstone Brand doxazosin tablets, 1 mg strength, oral tablets, containing 100 tablets. The label includes NDC 59762-1388-7 and states the drug is prescription only. It also notes storage instructions, active ingredient equivalence, manufacturing in Germany, and distribution by Greenstone LLC.*

FDA Label Image

Doxazosin Tablets Bottle Labels 2 mg (Image 05)

Label of doxazosin tablets 2 mg, human prescription drug by Greenstone, distributed by Greenstone LLC. The label shows a package of 100 tablets with storage instructions and barcode. The product is identified by NDC 59762-1389-7 and states each tablet contains 2 mg doxazosin mesylate equivalent to doxazosin free base.*

FDA Label Image

Doxazosin Tablets Bottle Labels 4 mg (Image 06)

The packaging label for Doxazosin mesylate tablets, 4 mg strength, contains 100 tablets. It is a prescription oral tablet drug under the Greenstone brand, distributed by Greenstone LLC, Morgantown WV, and manufactured in Germany. Storage instructions and dosage recommendations reference prescribing information.*

FDA Label Image

Doxazosin Tablets Bottle Labels 8 mg (Image 07)

Label for Doxazosin tablets 8 mg by Greenstone Brand, distributed by Greenstone LLC. The label specifies 100 tablets with NDC 59762-1391-7, storage instructions, and dosage information. The tablet contains doxazosin mesylate equivalent to 8 mg of doxazosin free base, made in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.